Global Equine Pharmaceuticals and Supplements Market Research Report 2026(Status and Outlook)
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent. In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.
The global Equine Pharmaceuticals and Supplements market size was estimated at USD 1253.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Equine Pharmaceuticals and Supplements market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Equine Pharmaceuticals and Supplements market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Equine Pharmaceuticals and Supplements market.
Global Equine Pharmaceuticals and Supplements Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Market Segmentation (by Type)
Pharmaceuticals
Supplements
Market Segmentation (by Application)
Thoroughbred Horse
Other Types of Horses
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Equine Pharmaceuticals and Supplements Market
Overview of the regional outlook of the Equine Pharmaceuticals and Supplements Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Pharmaceuticals and Supplements Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Equine Pharmaceuticals and Supplements, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Equine Pharmaceuticals and Supplements market size was estimated at USD 1253.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Equine Pharmaceuticals and Supplements market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Equine Pharmaceuticals and Supplements market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Equine Pharmaceuticals and Supplements market.
Global Equine Pharmaceuticals and Supplements Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Market Segmentation (by Type)
Pharmaceuticals
Supplements
Market Segmentation (by Application)
Thoroughbred Horse
Other Types of Horses
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Equine Pharmaceuticals and Supplements Market
Overview of the regional outlook of the Equine Pharmaceuticals and Supplements Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Pharmaceuticals and Supplements Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Equine Pharmaceuticals and Supplements, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Equine Pharmaceuticals and Supplements
1.2 Key Market Segments
1.2.1 Equine Pharmaceuticals and Supplements Segment by Type
1.2.2 Equine Pharmaceuticals and Supplements Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Equine Pharmaceuticals and Supplements Product Life Cycle
3.3 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2020-2025)
3.4 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2020-2025)
3.5 Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
3.8.1 Equine Pharmaceuticals and Supplements Market Concentration Rate
3.8.2 Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 EQUINE PHARMACEUTICALS AND SUPPLEMENTS INDUSTRY CHAIN ANALYSIS
4.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Equine Pharmaceuticals and Supplements Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Equine Pharmaceuticals and Supplements Market
5.7 ESG Ratings of Leading Companies
6 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
6.3 Global Equine Pharmaceuticals and Supplements Market Size by Type (2020-2025)
6.4 Global Equine Pharmaceuticals and Supplements Price by Type (2020-2025)
7 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Pharmaceuticals and Supplements Market Sales by Application (2020-2025)
7.3 Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2020-2025)
7.4 Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2020-2025)
8 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SALES BY REGION
8.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region
8.2 Global Equine Pharmaceuticals and Supplements Market Size by Region
8.2.1 Global Equine Pharmaceuticals and Supplements Market Size by Region
8.2.2 Global Equine Pharmaceuticals and Supplements Market Size by Region
8.3 North America
8.3.1 North America Equine Pharmaceuticals and Supplements Sales by Country
8.3.2 North America Equine Pharmaceuticals and Supplements Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Equine Pharmaceuticals and Supplements Sales by Country
8.4.2 Europe Equine Pharmaceuticals and Supplements Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region
8.5.2 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Equine Pharmaceuticals and Supplements Sales by Country
8.6.2 South America Equine Pharmaceuticals and Supplements Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region
8.7.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET PRODUCTION BY REGION
9.1 Global Production of Equine Pharmaceuticals and Supplements by Region(2020-2025)
9.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
9.3 Global Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Equine Pharmaceuticals and Supplements Production
9.4.1 North America Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
9.4.2 North America Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Equine Pharmaceuticals and Supplements Production
9.5.1 Europe Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
9.5.2 Europe Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Equine Pharmaceuticals and Supplements Production (2020-2025)
9.6.1 Japan Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
9.6.2 Japan Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Equine Pharmaceuticals and Supplements Production (2020-2025)
9.7.1 China Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
9.7.2 China Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Basic Information
10.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
10.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Market Performance
10.1.4 Boehringer Ingelheim Business Overview
10.1.5 Boehringer Ingelheim SWOT Analysis
10.1.6 Boehringer Ingelheim Recent Developments
10.2 Merck Animal Health
10.2.1 Merck Animal Health Basic Information
10.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
10.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
10.2.4 Merck Animal Health Business Overview
10.2.5 Merck Animal Health SWOT Analysis
10.2.6 Merck Animal Health Recent Developments
10.3 Zoetis
10.3.1 Zoetis Basic Information
10.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Overview
10.3.3 Zoetis Equine Pharmaceuticals and Supplements Product Market Performance
10.3.4 Zoetis Business Overview
10.3.5 Zoetis SWOT Analysis
10.3.6 Zoetis Recent Developments
10.4 Bayer Animal Health
10.4.1 Bayer Animal Health Basic Information
10.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
10.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
10.4.4 Bayer Animal Health Business Overview
10.4.5 Bayer Animal Health Recent Developments
10.5 Elanco Animal Health
10.5.1 Elanco Animal Health Basic Information
10.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
10.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
10.5.4 Elanco Animal Health Business Overview
10.5.5 Elanco Animal Health Recent Developments
10.6 Dechra Veterinary Products
10.6.1 Dechra Veterinary Products Basic Information
10.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
10.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Market Performance
10.6.4 Dechra Veterinary Products Business Overview
10.6.5 Dechra Veterinary Products Recent Developments
10.7 CEVA
10.7.1 CEVA Basic Information
10.7.2 CEVA Equine Pharmaceuticals and Supplements Product Overview
10.7.3 CEVA Equine Pharmaceuticals and Supplements Product Market Performance
10.7.4 CEVA Business Overview
10.7.5 CEVA Recent Developments
10.8 Virbac
10.8.1 Virbac Basic Information
10.8.2 Virbac Equine Pharmaceuticals and Supplements Product Overview
10.8.3 Virbac Equine Pharmaceuticals and Supplements Product Market Performance
10.8.4 Virbac Business Overview
10.8.5 Virbac Recent Developments
10.9 Norbrook Equine
10.9.1 Norbrook Equine Basic Information
10.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
10.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product Market Performance
10.9.4 Norbrook Equine Business Overview
10.9.5 Norbrook Equine Recent Developments
10.10 Kyoritsu Seiyaku
10.10.1 Kyoritsu Seiyaku Basic Information
10.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
10.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Market Performance
10.10.4 Kyoritsu Seiyaku Business Overview
10.10.5 Kyoritsu Seiyaku Recent Developments
10.11 Vetoquinol
10.11.1 Vetoquinol Basic Information
10.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
10.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product Market Performance
10.11.4 Vetoquinol Business Overview
10.11.5 Vetoquinol Recent Developments
10.12 Protexin Healthcare
10.12.1 Protexin Healthcare Basic Information
10.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
10.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Market Performance
10.12.4 Protexin Healthcare Business Overview
10.12.5 Protexin Healthcare Recent Developments
10.13 Audevard
10.13.1 Audevard Basic Information
10.13.2 Audevard Equine Pharmaceuticals and Supplements Product Overview
10.13.3 Audevard Equine Pharmaceuticals and Supplements Product Market Performance
10.13.4 Audevard Business Overview
10.13.5 Audevard Recent Developments
10.14 Ouro Fino Saude
10.14.1 Ouro Fino Saude Basic Information
10.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
10.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Market Performance
10.14.4 Ouro Fino Saude Business Overview
10.14.5 Ouro Fino Saude Recent Developments
11 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET FORECAST BY REGION
11.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast
11.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country
11.2.3 Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region
11.2.4 South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Equine Pharmaceuticals and Supplements by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Equine Pharmaceuticals and Supplements Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Equine Pharmaceuticals and Supplements by Type (2026-2035)
12.1.2 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Equine Pharmaceuticals and Supplements by Type (2026-2035)
12.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Application (2026-2035)
12.2.1 Global Equine Pharmaceuticals and Supplements Sales (K MT) Forecast by Application
12.2.2 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Equine Pharmaceuticals and Supplements
1.2 Key Market Segments
1.2.1 Equine Pharmaceuticals and Supplements Segment by Type
1.2.2 Equine Pharmaceuticals and Supplements Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Equine Pharmaceuticals and Supplements Product Life Cycle
3.3 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2020-2025)
3.4 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2020-2025)
3.5 Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
3.8.1 Equine Pharmaceuticals and Supplements Market Concentration Rate
3.8.2 Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 EQUINE PHARMACEUTICALS AND SUPPLEMENTS INDUSTRY CHAIN ANALYSIS
4.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Equine Pharmaceuticals and Supplements Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Equine Pharmaceuticals and Supplements Market
5.7 ESG Ratings of Leading Companies
6 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
6.3 Global Equine Pharmaceuticals and Supplements Market Size by Type (2020-2025)
6.4 Global Equine Pharmaceuticals and Supplements Price by Type (2020-2025)
7 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Pharmaceuticals and Supplements Market Sales by Application (2020-2025)
7.3 Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2020-2025)
7.4 Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2020-2025)
8 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SALES BY REGION
8.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region
8.2 Global Equine Pharmaceuticals and Supplements Market Size by Region
8.2.1 Global Equine Pharmaceuticals and Supplements Market Size by Region
8.2.2 Global Equine Pharmaceuticals and Supplements Market Size by Region
8.3 North America
8.3.1 North America Equine Pharmaceuticals and Supplements Sales by Country
8.3.2 North America Equine Pharmaceuticals and Supplements Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Equine Pharmaceuticals and Supplements Sales by Country
8.4.2 Europe Equine Pharmaceuticals and Supplements Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region
8.5.2 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Equine Pharmaceuticals and Supplements Sales by Country
8.6.2 South America Equine Pharmaceuticals and Supplements Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region
8.7.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET PRODUCTION BY REGION
9.1 Global Production of Equine Pharmaceuticals and Supplements by Region(2020-2025)
9.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
9.3 Global Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Equine Pharmaceuticals and Supplements Production
9.4.1 North America Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
9.4.2 North America Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Equine Pharmaceuticals and Supplements Production
9.5.1 Europe Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
9.5.2 Europe Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Equine Pharmaceuticals and Supplements Production (2020-2025)
9.6.1 Japan Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
9.6.2 Japan Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Equine Pharmaceuticals and Supplements Production (2020-2025)
9.7.1 China Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
9.7.2 China Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Basic Information
10.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
10.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Market Performance
10.1.4 Boehringer Ingelheim Business Overview
10.1.5 Boehringer Ingelheim SWOT Analysis
10.1.6 Boehringer Ingelheim Recent Developments
10.2 Merck Animal Health
10.2.1 Merck Animal Health Basic Information
10.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
10.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
10.2.4 Merck Animal Health Business Overview
10.2.5 Merck Animal Health SWOT Analysis
10.2.6 Merck Animal Health Recent Developments
10.3 Zoetis
10.3.1 Zoetis Basic Information
10.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Overview
10.3.3 Zoetis Equine Pharmaceuticals and Supplements Product Market Performance
10.3.4 Zoetis Business Overview
10.3.5 Zoetis SWOT Analysis
10.3.6 Zoetis Recent Developments
10.4 Bayer Animal Health
10.4.1 Bayer Animal Health Basic Information
10.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
10.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
10.4.4 Bayer Animal Health Business Overview
10.4.5 Bayer Animal Health Recent Developments
10.5 Elanco Animal Health
10.5.1 Elanco Animal Health Basic Information
10.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
10.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
10.5.4 Elanco Animal Health Business Overview
10.5.5 Elanco Animal Health Recent Developments
10.6 Dechra Veterinary Products
10.6.1 Dechra Veterinary Products Basic Information
10.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
10.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Market Performance
10.6.4 Dechra Veterinary Products Business Overview
10.6.5 Dechra Veterinary Products Recent Developments
10.7 CEVA
10.7.1 CEVA Basic Information
10.7.2 CEVA Equine Pharmaceuticals and Supplements Product Overview
10.7.3 CEVA Equine Pharmaceuticals and Supplements Product Market Performance
10.7.4 CEVA Business Overview
10.7.5 CEVA Recent Developments
10.8 Virbac
10.8.1 Virbac Basic Information
10.8.2 Virbac Equine Pharmaceuticals and Supplements Product Overview
10.8.3 Virbac Equine Pharmaceuticals and Supplements Product Market Performance
10.8.4 Virbac Business Overview
10.8.5 Virbac Recent Developments
10.9 Norbrook Equine
10.9.1 Norbrook Equine Basic Information
10.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
10.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product Market Performance
10.9.4 Norbrook Equine Business Overview
10.9.5 Norbrook Equine Recent Developments
10.10 Kyoritsu Seiyaku
10.10.1 Kyoritsu Seiyaku Basic Information
10.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
10.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Market Performance
10.10.4 Kyoritsu Seiyaku Business Overview
10.10.5 Kyoritsu Seiyaku Recent Developments
10.11 Vetoquinol
10.11.1 Vetoquinol Basic Information
10.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
10.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product Market Performance
10.11.4 Vetoquinol Business Overview
10.11.5 Vetoquinol Recent Developments
10.12 Protexin Healthcare
10.12.1 Protexin Healthcare Basic Information
10.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
10.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Market Performance
10.12.4 Protexin Healthcare Business Overview
10.12.5 Protexin Healthcare Recent Developments
10.13 Audevard
10.13.1 Audevard Basic Information
10.13.2 Audevard Equine Pharmaceuticals and Supplements Product Overview
10.13.3 Audevard Equine Pharmaceuticals and Supplements Product Market Performance
10.13.4 Audevard Business Overview
10.13.5 Audevard Recent Developments
10.14 Ouro Fino Saude
10.14.1 Ouro Fino Saude Basic Information
10.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
10.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Market Performance
10.14.4 Ouro Fino Saude Business Overview
10.14.5 Ouro Fino Saude Recent Developments
11 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET FORECAST BY REGION
11.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast
11.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country
11.2.3 Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region
11.2.4 South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Equine Pharmaceuticals and Supplements by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Equine Pharmaceuticals and Supplements Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Equine Pharmaceuticals and Supplements by Type (2026-2035)
12.1.2 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Equine Pharmaceuticals and Supplements by Type (2026-2035)
12.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Application (2026-2035)
12.2.1 Global Equine Pharmaceuticals and Supplements Sales (K MT) Forecast by Application
12.2.2 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 4. Global Equine Pharmaceuticals and Supplements Market Size by Application
Table 5. Equine Pharmaceuticals and Supplements Market Size Comparison by Region (M USD)
Table 6. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Equine Pharmaceuticals and Supplements Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2025)
Table 11. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Equine Pharmaceuticals and Supplements Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Equine Pharmaceuticals and Supplements Sales by Type (K MT)
Table 27. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 28. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Type (2020-2025)
Table 29. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
Table 30. Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2020-2025)
Table 31. Global Equine Pharmaceuticals and Supplements Market Share by Type (2020-2025)
Table 32. Global Equine Pharmaceuticals and Supplements Price (USD/KG) by Type (2020-2025)
Table 33. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Application
Table 34. Global Equine Pharmaceuticals and Supplements Market Size by Application
Table 35. Global Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K MT)
Table 36. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Table 37. Global Equine Pharmaceuticals and Supplements Market Size by Application (2020-2025) & (M USD)
Table 38. Global Equine Pharmaceuticals and Supplements Market Share by Application (2020-2025)
Table 39. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2020-2025)
Table 40. Global Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K MT)
Table 41. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2025)
Table 42. Global Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025) & (M USD)
Table 43. Global Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025)
Table 44. North America Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K MT)
Table 45. North America Equine Pharmaceuticals and Supplements Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K MT)
Table 47. Europe Equine Pharmaceuticals and Supplements Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025) & (M USD)
Table 50. South America Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K MT)
Table 51. South America Equine Pharmaceuticals and Supplements Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025) & (M USD)
Table 54. Global Equine Pharmaceuticals and Supplements Production (K MT) by Region(2020-2025)
Table 55. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
Table 57. Global Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Boehringer Ingelheim Basic Information
Table 63. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
Table 64. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim SWOT Analysis
Table 67. Boehringer Ingelheim Recent Developments
Table 68. Merck Animal Health Basic Information
Table 69. Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 70. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Animal Health Business Overview
Table 72. Merck Animal Health SWOT Analysis
Table 73. Merck Animal Health Recent Developments
Table 74. Zoetis Basic Information
Table 75. Zoetis Equine Pharmaceuticals and Supplements Product Overview
Table 76. Zoetis Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Zoetis Business Overview
Table 78. Zoetis SWOT Analysis
Table 79. Zoetis Recent Developments
Table 80. Bayer Animal Health Basic Information
Table 81. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 82. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Animal Health Business Overview
Table 84. Bayer Animal Health Recent Developments
Table 85. Elanco Animal Health Basic Information
Table 86. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 87. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Elanco Animal Health Business Overview
Table 89. Elanco Animal Health Recent Developments
Table 90. Dechra Veterinary Products Basic Information
Table 91. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
Table 92. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Dechra Veterinary Products Business Overview
Table 94. Dechra Veterinary Products Recent Developments
Table 95. CEVA Basic Information
Table 96. CEVA Equine Pharmaceuticals and Supplements Product Overview
Table 97. CEVA Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CEVA Business Overview
Table 99. CEVA Recent Developments
Table 100. Virbac Basic Information
Table 101. Virbac Equine Pharmaceuticals and Supplements Product Overview
Table 102. Virbac Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Virbac Business Overview
Table 104. Virbac Recent Developments
Table 105. Norbrook Equine Basic Information
Table 106. Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
Table 107. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Norbrook Equine Business Overview
Table 109. Norbrook Equine Recent Developments
Table 110. Kyoritsu Seiyaku Basic Information
Table 111. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
Table 112. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Kyoritsu Seiyaku Business Overview
Table 114. Kyoritsu Seiyaku Recent Developments
Table 115. Vetoquinol Basic Information
Table 116. Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
Table 117. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Vetoquinol Business Overview
Table 119. Vetoquinol Recent Developments
Table 120. Protexin Healthcare Basic Information
Table 121. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
Table 122. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Protexin Healthcare Business Overview
Table 124. Protexin Healthcare Recent Developments
Table 125. Audevard Basic Information
Table 126. Audevard Equine Pharmaceuticals and Supplements Product Overview
Table 127. Audevard Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Audevard Business Overview
Table 129. Audevard Recent Developments
Table 130. Ouro Fino Saude Basic Information
Table 131. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
Table 132. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Ouro Fino Saude Business Overview
Table 134. Ouro Fino Saude Recent Developments
Table 135. Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Equine Pharmaceuticals and Supplements Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Equine Pharmaceuticals and Supplements Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Equine Pharmaceuticals and Supplements Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 4. Global Equine Pharmaceuticals and Supplements Market Size by Application
Table 5. Equine Pharmaceuticals and Supplements Market Size Comparison by Region (M USD)
Table 6. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Equine Pharmaceuticals and Supplements Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2025)
Table 11. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Equine Pharmaceuticals and Supplements Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Equine Pharmaceuticals and Supplements Sales by Type (K MT)
Table 27. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 28. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Type (2020-2025)
Table 29. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
Table 30. Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2020-2025)
Table 31. Global Equine Pharmaceuticals and Supplements Market Share by Type (2020-2025)
Table 32. Global Equine Pharmaceuticals and Supplements Price (USD/KG) by Type (2020-2025)
Table 33. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Application
Table 34. Global Equine Pharmaceuticals and Supplements Market Size by Application
Table 35. Global Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K MT)
Table 36. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Table 37. Global Equine Pharmaceuticals and Supplements Market Size by Application (2020-2025) & (M USD)
Table 38. Global Equine Pharmaceuticals and Supplements Market Share by Application (2020-2025)
Table 39. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2020-2025)
Table 40. Global Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K MT)
Table 41. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2025)
Table 42. Global Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025) & (M USD)
Table 43. Global Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025)
Table 44. North America Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K MT)
Table 45. North America Equine Pharmaceuticals and Supplements Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K MT)
Table 47. Europe Equine Pharmaceuticals and Supplements Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025) & (M USD)
Table 50. South America Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K MT)
Table 51. South America Equine Pharmaceuticals and Supplements Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025) & (M USD)
Table 54. Global Equine Pharmaceuticals and Supplements Production (K MT) by Region(2020-2025)
Table 55. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
Table 57. Global Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Boehringer Ingelheim Basic Information
Table 63. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
Table 64. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim SWOT Analysis
Table 67. Boehringer Ingelheim Recent Developments
Table 68. Merck Animal Health Basic Information
Table 69. Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 70. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Animal Health Business Overview
Table 72. Merck Animal Health SWOT Analysis
Table 73. Merck Animal Health Recent Developments
Table 74. Zoetis Basic Information
Table 75. Zoetis Equine Pharmaceuticals and Supplements Product Overview
Table 76. Zoetis Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Zoetis Business Overview
Table 78. Zoetis SWOT Analysis
Table 79. Zoetis Recent Developments
Table 80. Bayer Animal Health Basic Information
Table 81. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 82. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Animal Health Business Overview
Table 84. Bayer Animal Health Recent Developments
Table 85. Elanco Animal Health Basic Information
Table 86. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 87. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Elanco Animal Health Business Overview
Table 89. Elanco Animal Health Recent Developments
Table 90. Dechra Veterinary Products Basic Information
Table 91. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
Table 92. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Dechra Veterinary Products Business Overview
Table 94. Dechra Veterinary Products Recent Developments
Table 95. CEVA Basic Information
Table 96. CEVA Equine Pharmaceuticals and Supplements Product Overview
Table 97. CEVA Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CEVA Business Overview
Table 99. CEVA Recent Developments
Table 100. Virbac Basic Information
Table 101. Virbac Equine Pharmaceuticals and Supplements Product Overview
Table 102. Virbac Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Virbac Business Overview
Table 104. Virbac Recent Developments
Table 105. Norbrook Equine Basic Information
Table 106. Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
Table 107. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Norbrook Equine Business Overview
Table 109. Norbrook Equine Recent Developments
Table 110. Kyoritsu Seiyaku Basic Information
Table 111. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
Table 112. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Kyoritsu Seiyaku Business Overview
Table 114. Kyoritsu Seiyaku Recent Developments
Table 115. Vetoquinol Basic Information
Table 116. Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
Table 117. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Vetoquinol Business Overview
Table 119. Vetoquinol Recent Developments
Table 120. Protexin Healthcare Basic Information
Table 121. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
Table 122. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Protexin Healthcare Business Overview
Table 124. Protexin Healthcare Recent Developments
Table 125. Audevard Basic Information
Table 126. Audevard Equine Pharmaceuticals and Supplements Product Overview
Table 127. Audevard Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Audevard Business Overview
Table 129. Audevard Recent Developments
Table 130. Ouro Fino Saude Basic Information
Table 131. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
Table 132. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Ouro Fino Saude Business Overview
Table 134. Ouro Fino Saude Recent Developments
Table 135. Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Equine Pharmaceuticals and Supplements Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Equine Pharmaceuticals and Supplements Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Equine Pharmaceuticals and Supplements Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Equine Pharmaceuticals and Supplements
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Pharmaceuticals and Supplements Market Size (M USD), 2025-2035
Figure 5. Global Equine Pharmaceuticals and Supplements Market Size (M USD) (2020-2035)
Figure 6. Global Equine Pharmaceuticals and Supplements Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Pharmaceuticals and Supplements Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Equine Pharmaceuticals and Supplements Product Life Cycle
Figure 13. Equine Pharmaceuticals and Supplements Sales Share by Manufacturers in 2025
Figure 14. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2025
Figure 15. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Equine Pharmaceuticals and Supplements Revenue in 2025
Figure 18. Industry Chain Map of Equine Pharmaceuticals and Supplements
Figure 19. Global Equine Pharmaceuticals and Supplements Market PEST Analysis
Figure 20. Global Equine Pharmaceuticals and Supplements Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Equine Pharmaceuticals and Supplements Market Share by Type
Figure 27. Sales Market Share of Equine Pharmaceuticals and Supplements by Type (2020-2025)
Figure 28. Sales Market Share of Equine Pharmaceuticals and Supplements by Type in 2025
Figure 29. Market Share of Equine Pharmaceuticals and Supplements by Type (2020-2025)
Figure 30. Market Share of Equine Pharmaceuticals and Supplements by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Equine Pharmaceuticals and Supplements Market Share by Application
Figure 33. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 34. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2025
Figure 35. Global Equine Pharmaceuticals and Supplements Market Share by Application (2020-2025)
Figure 36. Global Equine Pharmaceuticals and Supplements Market Share by Application in 2025
Figure 37. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2020-2025)
Figure 38. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2025)
Figure 39. Global Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025)
Figure 40. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2024
Figure 43. North America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Equine Pharmaceuticals and Supplements Market Size by Country in 2024
Figure 45. U.S. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Equine Pharmaceuticals and Supplements Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Equine Pharmaceuticals and Supplements Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Equine Pharmaceuticals and Supplements Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Equine Pharmaceuticals and Supplements Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2024
Figure 53. Europe Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Equine Pharmaceuticals and Supplements Market Size by Country in 2024
Figure 55. Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2024
Figure 67. Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region in 2024
Figure 68. China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (K MT)
Figure 79. South America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2024
Figure 80. South America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (M USD)
Figure 81. South America Equine Pharmaceuticals and Supplements Market Size by Country in 2024
Figure 82. Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Region in 2024
Figure 92. Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Equine Pharmaceuticals and Supplements Production Market Share by Region (2020-2025)
Figure 103. North America Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 106. China Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Equine Pharmaceuticals and Supplements Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2026-2035)
Figure 111. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2026-2035)
Figure 112. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Equine Pharmaceuticals and Supplements
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Pharmaceuticals and Supplements Market Size (M USD), 2025-2035
Figure 5. Global Equine Pharmaceuticals and Supplements Market Size (M USD) (2020-2035)
Figure 6. Global Equine Pharmaceuticals and Supplements Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Pharmaceuticals and Supplements Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Equine Pharmaceuticals and Supplements Product Life Cycle
Figure 13. Equine Pharmaceuticals and Supplements Sales Share by Manufacturers in 2025
Figure 14. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2025
Figure 15. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Equine Pharmaceuticals and Supplements Revenue in 2025
Figure 18. Industry Chain Map of Equine Pharmaceuticals and Supplements
Figure 19. Global Equine Pharmaceuticals and Supplements Market PEST Analysis
Figure 20. Global Equine Pharmaceuticals and Supplements Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Equine Pharmaceuticals and Supplements Market Share by Type
Figure 27. Sales Market Share of Equine Pharmaceuticals and Supplements by Type (2020-2025)
Figure 28. Sales Market Share of Equine Pharmaceuticals and Supplements by Type in 2025
Figure 29. Market Share of Equine Pharmaceuticals and Supplements by Type (2020-2025)
Figure 30. Market Share of Equine Pharmaceuticals and Supplements by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Equine Pharmaceuticals and Supplements Market Share by Application
Figure 33. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 34. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2025
Figure 35. Global Equine Pharmaceuticals and Supplements Market Share by Application (2020-2025)
Figure 36. Global Equine Pharmaceuticals and Supplements Market Share by Application in 2025
Figure 37. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2020-2025)
Figure 38. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2025)
Figure 39. Global Equine Pharmaceuticals and Supplements Market Size by Region (2020-2025)
Figure 40. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2024
Figure 43. North America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Equine Pharmaceuticals and Supplements Market Size by Country in 2024
Figure 45. U.S. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Equine Pharmaceuticals and Supplements Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Equine Pharmaceuticals and Supplements Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Equine Pharmaceuticals and Supplements Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Equine Pharmaceuticals and Supplements Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2024
Figure 53. Europe Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Equine Pharmaceuticals and Supplements Market Size by Country in 2024
Figure 55. Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2024
Figure 67. Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region in 2024
Figure 68. China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (K MT)
Figure 79. South America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2024
Figure 80. South America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (M USD)
Figure 81. South America Equine Pharmaceuticals and Supplements Market Size by Country in 2024
Figure 82. Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Region in 2024
Figure 92. Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Equine Pharmaceuticals and Supplements Production Market Share by Region (2020-2025)
Figure 103. North America Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 106. China Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Equine Pharmaceuticals and Supplements Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2026-2035)
Figure 111. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2026-2035)
Figure 112. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2026-2035)
